Background: In part 1 of this study it was shown that liposuctioned fat could be a sufficient source of autologous collagen for use as a filler or in reconstruction. The collagen composition in liposuctioned fat was shown to form a cross-linked helical matrix composed of types II, III, and IV. Additionally, viable adipocytes and fibroblasts among other cells were found. Objectives: The purpose of this research was to study the biology of this matrix after subsequent implantation compared to Juvederm (Allergan, Parsippany, NJ) common soft tissue filler. Methods: Fat was obtained from individuals undergoing routine liposuction and was processed by a two-step process to obtain a connective tissue matrix. The matrix was then cryo-frozen for a minimum of 4 weeks after which it was thawed and implanted in 46 nude mice. Juvederm Ultra was used as the control article and the animals followed for one year. Results: Liposuctioned fat was obtained from 10 individuals and processed as previously described. Mice were harvested at 3, 6, 9, and 12 months and histology obtained. There were no adverse effects from either article and the bio-reactivity rating was 0. The implanted collagen compared favorably to Juvederm at all stages and was found to be replaced by new collagen and fat. Conclusions: A collagen matrix with viable cells for autologous use can be obtained from liposuctioned fat which has been processed and cryo-frozen. The material lasts at least one year and is slowly replaced by new collagenand fat.
Level of Evidence: 5
Editorial Decision date: February 10, 2017; online publish-ahead-of-print May 16, 2017. Autologous collagen is the ideal injectable soft tissue filler and may serve as a matrix for stem cell implantation and subsequent growth in regenerative medicine. 1, 2 Other nonautologous fillers are associated with limitations and risks which can be minimized but not eliminated. 3 Procurement of autologous collagen, however, has been limited secondary to a lack of a sufficient source. In addition, the tissue processing technology has been complex and cost-prohibitive. Liposuction is a widely performed procedure where the average amount of fat removed ranges greatly, but typically a minimum of 300 cc of fat is routinely removed. This fat could be a source of autologous collagen. In part I of this study we showed that an autologous collagen matrix with cells can be easily and quickly obtained from liposuctioned fat without alteration of the overall cellular composition or structure of the adipose connective tissue. 4 The amount of collagen per 100 mL of fat is low at 1 mL but this is compensated for by the large amount of fat available for harvesting. Stromal cells, including fat and fibroblasts, remain viable after processing. The purpose of this research was to evaluate the collagen matrix for local tissue response, absorption, and the potential to induce toxic effects after implantation.
METHODS
This study consisted of two parts. The first part was conducted in compliance with the current US Food and Drug Administration 21 CFR, Part 58 Good Laboratory Practices for Nonclinical Studies. The study was performed under the direction of Toxikon Corporation (Bedford, MA). Toxikon is a well-known animal research facility where the animals were housed and cared for during the study. The second part of the study was performed according to the Helsinki provisions and under Internal Review Board approval from Stanford University. The entire study ran from January 2013 through December 2016. Forty-three athymic nude mice (Mus musculus) were used in part 1, to evaluate the filler material in regards to volume and integration into the host tissue. All mice were males with a weight between 23.2 to 33.0 grams (average, 28.9 grams) and were at least 6 weeks old. The test article, collagen matrix was prepared from human liposuctioned fat by ultrasound processing and filtering as per the first part of the study. 4 The test article sample was based on 12 individuals with varying amounts from each individual depending on the amount of fat obtained from liposuction. All individuals were female with an average of 42 years (range, 30-62 years). The test article was cryo-stored for a minimum of 2 months by protocol since it was assumed that this would demonstrate the affect of cryo-storage for a short interval. The cryo-storage technique was similar to that for cord blood which is a well established and documented technique that is widely used. It was thawed 24 hours prior to implantation. The samples were taken from the cryo-storage and packed in a mailing container and allowed to gradually assume room temperature during transport. It was assumed that this would mimic delivery of the tissue matrix from implantation under normal circumstances. Prior to cryo-storing each sample was tested for bacterial contamination. Any sample that tested positive was discarded. The samples were blindly selected for administration by placing the individual 1 cc containers of the tissue matrix on the table and taking one in a blinded fashion at the time each animal was injected.
The control article was Juvederm Ultra (Allergan, Parsippany, NJ). Both the collagen matrix and control article were administered via a subcutaneous injection of 0.8 mL of each on opposite flanks of the same animal. The control and the test article were injected through a 25-gauge needle. Prior to implantation, each animal was appropriately anesthetized and the surgical area swabbed with a surgical preparation solution. Animals were observed daily to ensure proper healing of the implant sites and for signs of toxicity. Animals whose condition made it unlikely that they would survive were sacrificed immediately and the subcutaneous implant sites collected immediately. At the end of the observation period, the remaining animals in each group were weighed and sacrificed by carbon dioxide inhalation. Eight mice were sacrificed at each 1, 3, 6, and 9 months and 10 mice at the 12-month time period. The subcutaneous tissue was excised in toto from each animal by careful slicing around the implant sites with a scalpel. The excised implant tissues were weighed and examined grossly. The collected tissues were then placed in properly labeled containers containing 10% neutral buffered formalin. Following fixation each implant site was excised from the larger mass of tissue. The implant area containing the implant site was examined macroscopically for signs of inflammation, encapsulation, hemorrhaging, necrosis, and discoloration using the following scale; 0=normal, 1=mild, 2= moderate, and 3= severe. After macroscopic examination, the implant material was left in situ and a slice of tissue containing the implant was processed. Histologic slides were prepared using hematoxylin and eosin and Masson's trichrome stains. The slides were examined by a pathologist and the histological response noted. The relative size of the involved area was assessed in relation to the surrounding normal tissue. The one-month implant sites served as a baseline for later comparison. The absorption was rated as 0= no test article present, 1=trace amount, 2= minimal, 3= moderate amount, 4= extensive test article remaining.
Bioreactivity rating was calculated for each time period based on the extent of the inflammatory response. A negative correlation was rated at 0. No reaction from 0.0 to 2.9, slight reaction 3.0 to 8.9, moderate reaction 9.0 to 15.0, and a severe reaction >15.
In part 2, the collagen matrix was immediately injected in the 3 patients at the same time as the liposuction. 0.8 mL of collagen was implanted behind the right ear in each subject. These subjects were treated by liposuction and adipose transfer for facial rejuvenation. They were also consented for implantation of a small amount of autologous collagen behind the ear for later biopsy. Figure 1 . Visual exam at one week, 3 months, and 6 months demonstrated no reaction at the implant site. At 6 months the sites were biopsied under local anesthesia and the tissue stained using hematoxylin and eosin and examined microscopically.
RESULTS
No clinical signs during the study were attributed to the test article. Edema was noted in some sites but did not affect animal behavior and was most frequent at the control sites. On days 113 and 114 animals number 43 and 42, cage mates, were humanely euthanized due to significant signs of labored breathing and lethargy due to the immunocompromised nature of the animals. Macroscopic evaluation of the test and control articles indicated no significant signs of inflammation, encapsulation, hemorrhage necrosis, or discoloration at any time point.
Microscopic observation at one month showed a light blue material at the control sites. Residual test article was composed of collagen-like and adipocytes-like tissue. The amount of control was slightly more than the test article at one month. Inflammatory cell infiltration was minimal at test and control sites. The test article was found to be nonreactive.
At 3 months examination demonstrated variable amounts of collagen-like and fat-like tissue and the residual control article was slightly more in quantity then the test article. However, there were good quantities of both articles present (Figures 2-3) . Again the test material was found to be nonreactive. At 6 months the appearance of the test article was similar to previous and the amount of test article was not significantly different then the amount of the control article and was similar to the one-month and three-month time points. The test article continued to be rated nonreactive. The appearance of the test article remained much the same at 9 months except that there was more collagen at the test sites then the control sites. The amount of test article decreased when compared to the previous time periods and test article. The test article remained nonreactive. At 12 months most of the residual control article remained in situ. The residual test article was still present in large quantities but less than the control article. It was composed of collagen and fat cells in variable amounts in different animals based on the differences in the test article (Figures 4-6 ).
In the human subjects the microscopic examination of the collagen matrix implant at 6 months demonstrated a large amount of dense collagen with no surrounding reaction ( Figure 7 ).
DISCUSSION
The collagen matrix (test article) was compared to Juvederm Ultra, a commonly used and widely accepted hyaluronic acid filler (HA). Juvederm has been used previously as a control article and is widely used as a filler. 5 There was found to be little to no inflammatory response with both the collagen matrix test article and Juvederm. The collagen matrix was found to resorb slowly and to be replaced by new adipose tissue and collagen. Juvederm was only resorbed as was seen in this study. At the end of one year both the test and control articles were present. The tissue matrix in this study produced by cross-linking collagen thus lasts much longer than simple collagen matrices previously studied which all resorbed in 6 months. The longer retention of the test article tissue matrix makes it superior to the previous collagen fillers and comparable to HA fillers in this regard. The long term retention of the test article and fate of the new collagen and fat seen in the 9 and 12 month animals remains unknown but logically should remain stable. The present autologous tissue matrix appears to be a good candidate to use as a soft tissue filler since it lasts at least 12 months, is injected through a fine gauge needle, and presents with new tissue growth from cells in the matrix. Additionally, the filler can be stored cryogenically and delivered when needed. No deleterious effects were found from storing the test samples cryogenically in this study.
A number of biomaterials have been studied in regard to adipose tissue regeneration. Synthetic polymers have been shown insufficient and natural polymers such as collagen and HA have suffered from rapid resorption. In addition, a cellular implants without a good matrix have demonstrated only limited formation of adipose tissue. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Recently, an injectable matrix scaffold produced from decellularized lipoaspirate has been shown as a hydrogel that supports growth of matched adipose derived stem cells seeded into the matrix in vitro. [17] [18] [19] [20] [21] This is an advance from previous adipose derived scaffolds which required surgical implantation. The autologous collagen matrix in this study may also be an option for adipose tissue engineering providing both a scaffold and cells which can be injected. The SEM images of this matrix are very similar to the hydrogel collagen matrix of Young et al, however they are produced by completely different methodologies. 17 Kim et al also found excellent results with a cross-linked hyaluronic acid and human collagen filler as a regenerative matrix. 18 The test collagen matrix in this article compares favorably with both of these regenerative matrices and may also serve as a matrix for adipose regeneration. The present matrix is superior as it is already naturally seeded with autologous adipose cells and the process is thus just one step.
Previously, several studies have shown that freezing has a negative effect on graft retention when compared to freshly injected fat in the nude mouse model. 22, 23 Cryopreserved fat performed better then fat which was simply frozen. 24 This study did not look at that issue, however it can be seen by this study that cells do survive and grow after treatment to include cryo-freezing.
Both liposuction and the use of fillers are common procedures in aesthetic surgery. Other than fat transfer cases, the fat liposuctioned is discarded at the end of the procedure. If this lipoasirate can be turned into a tissue matrix it could be used in later aesthetic applications as a filler which could include lip augmentation, nasolabial folds, and other rhytids. Collagen has also been used in other medical applications for which this may be ideal such as vocal folds and urethral stress incontinence. 25, 26 In all these cases an autologous tissue with viable cells would seem ideal. Processing of the fat and then cryo-storage of the tissue matrix would make the product available on demand without the need to perform additional harvesting techniques.
This study adds to the accumulating data regarding autologous tissues and cells for regenerative medicine and surgery. Limitations of this study include its small size and the short duration of implantation in the human subject.
CONCLUSION
The collagen matrix test article and the control article Juvederm were implanted in the subcutaneous tissue of Athymic nude mice for a period of 1, 3, 6, 9, and 12 months. At the time points after 6 months there was a greater amount of residual control article as compared to the test article. The test article, however, had converted to a greater percentage of new collagen and fat as compared to the control article. The results also indicate that the test article does not demonstrate any difference in bioreactivity, rating 0, as compared to the control implant sites at all time periods. Autologous collagen matrix appears to be an excellent material for use as a soft tissue filler as it is long lasting, injected through a fine needle, available in moderate quantities on demand, and has no apparent bioreactivity.
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